EpCAM-autoantibody levels in the course of disease of ovarian cancer patients

Medical Oncology

Volumn 28, Issue 2, 2011, Pages 626-630

  Heubner, Martin ^a   Errico, Dino ^a   Kasimir Bauer, Sabine ^a   Herlyn, Dorothee ^b   Kimmig, Rainer ^a   Wimberger, Pauline ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b WISTAR INSTITUTE   (United States)

Author keywords

Autoantibody; EpCAM; Ovarian cancer; Tumor immunity

Indexed keywords

ANTINEOPLASTIC AGENT; AUTOANTIBODY; EPITHELIAL CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE ANTIBODY; PLATINUM; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY TITER; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; OMENTECTOMY; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; SALPINGOOOPHORECTOMY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; ANTINEOPLASTIC AGENTS; AUTOANTIBODIES; AUTOANTIGENS; CELL ADHESION MOLECULES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; YOUNG ADULT;

EID: 79960308763     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9486-3     Document Type: Article

References (22)

1. MT Goodman, et al. 2003 Incidence of ovarian cancer by race and ethnicity in the United States, 1992-1997 Cancer 97 10 Suppl 2676 2685 12733132 10.1002/cncr.11349 (Pubitemid 36539068)
2. SV Litvinov MP Velders HA Bakker GJ Fleuren SO Warnaar 1994 Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule J Cell Biol 125 2 437 446 8163559 10.1083/jcb.125.2.437 1:CAS:528:DyaK2cXisVWhurs%3D (Pubitemid 24135956)
3. F Momburg G Moldenhauer GJ Hammerling P Moller 1987 Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues Cancer Res 47 11 2883 2891 3552208 1:CAS:528:DyaL2sXkvFCntLs%3D (Pubitemid 17113431)
4. D Maetzel, et al. 2009 Nuclear signalling by tumour-associated antigen EpCAM Nat Cell Biol 11 2 162 171 19136966 10.1038/ncb1824 1:CAS:528: DC%2BD1MXht1Oqt7w%3D
5. M Munz, et al. 2004 The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation Oncogene 23 34 5748 5758 15195135 10.1038/sj.onc.1207610 (Pubitemid 39093020)
6. SV Litvinov, et al. 1997 Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins J Cell Biol 139 5 1337 1348 9382878 10.1083/jcb.139.5.1337 1:CAS:528:DyaK2sXnvFeqsb8%3D (Pubitemid 27523219)
7. MJ Winter ID Nagtegaal JH van Krieken SV Litvinov 2003 The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology Am J Pathol 163 6 2139 2148 14633587 10.1016/S0002-9440(10) 63570-5 1:CAS:528:DC%2BD2cXkslCh (Pubitemid 37466457)
8. A Burges, et al. 2007 Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study Clin Cancer Res 13 13 3899 3905 17606723 10.1158/1078-0432. CCR-06-2769 1:CAS:528:DC%2BD2sXntFymtrc%3D (Pubitemid 47037597)
9. S Mosolits, et al. 1999 Autoantibodies against the tumour-associated antigen GA733-2 in patients with colorectal carcinoma Cancer Immunol Immunother 47 6 315 320 10203061 10.1007/s002620050536 1:STN:280:DyaK1M3hslOisw%3D%3D (Pubitemid 29151830)
10. JH Kim, et al. 2003 Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer Clin Cancer Res 9 13 4782 4791 14581349 1:CAS:528:DC%2BD3sXosVGjsb0%3D
11. MJ Turk JD Wolchok JA Guevara-Patino SM Goldberg AN Houghton 2002 Multiple pathways to tumor immunity and concomitant autoimmunity Immunol Rev 188 122 135 12445286 10.1034/j.1600-065X.2002.18811.x 1:CAS:528: DC%2BD38Xps1OqsrY%3D (Pubitemid 35398870)
12. CA Marcos, et al. 2009 The usefulness of new serum tumor markers in head and neck squamous cell carcinoma Otolaryngol Head Neck Surg 140 3 375 380 19248946 10.1016/j.otohns.2008.12.026
13. E Gumus, et al. 2004 Association of positive serum anti-p53 antibodies with poor prognosis in bladder cancer patients Int J Urol 11 12 1070 1077 15663677 10.1111/j.1442-2042.2004.00948.x (Pubitemid 40053006)
14. YT Lee KM Sheikh FP Quismorio Jr GJ Friou 1985 Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis Breast Cancer Res Treat 6 1 57 65 3902126 10.1007/BF01806011 1:STN:280: DyaL28%2Fis1OqtA%3D%3D (Pubitemid 15241230)
15. Y Yamazaki, et al. 2008 Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma Odontology 96 1 32 37 18661202 10.1007/s10266-008-0079-y 1:CAS:528:DC%2BD1cXpsVGlsbY%3D
16. J Pfisterer, et al. 2006 The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR Ann Oncol 17 10 1568 1577 17005631 10.1093/annonc/mdl357 1:STN:280: DC%2BD28nos1Cjtw%3D%3D (Pubitemid 44548850)
17. T Sittler, et al. 2008 Concerted potent humoral immune responses to autoantigens are associated with tumor destruction and favorable clinical outcomes without autoimmunity Clin Cancer Res 14 12 3896 3905 18559611 10.1158/1078-0432.CCR-07-4782 1:CAS:528:DC%2BD1cXntlWrtLg%3D
18. Lee KR et al. Surface epithelial-stromal tumours. World Health Organization Classification of Tumours. Tumours of the Breast and Female Genital Organs. Lyon: IARC Press; 2003. pp 117-45.
19. SG Silverberg 2000 Histopathologic grading of ovarian carcinoma: a review and proposal Int J Gynecol Pathol 19 1 7 15 10638449 10.1097/00004347- 200001000-00003 1:STN:280:DC%2BD3c7gtlyjtg%3D%3D (Pubitemid 30010638)
20. FIGO. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2009;105(1):3-4.
21. CP Strassburg, et al. 1992 Baculovirus recombinant expressing a secreted form of a transmembrane carcinoma-associated antigen Cancer Res 52 4 815 821 1737342 1:CAS:528:DyaK38Xht1KntLg%3D
22. H Abe, et al. 2002 Preparation of recombinant MK-1/Ep-CAM and establishment of an ELISA system for determining soluble MK-1/Ep-CAM levels in sera of cancer patients J Immunol Methods 270 2 227 233 12379327 1:CAS:528:DC%2BD38XnvVOntLc%3D